搜索筛选:
搜索耗时1.5314秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-s
[期刊论文] 作者：Haiyan Xu,Di Ma,Guangjian Yang,
来源：中国癌症研究:英文版 年份：2019
Objective: Crizotinib is recommended as the first-line therapy for advanced anaplastic lymphoma kinase(ALK)-positive non-small-cell lung cancer(NSCLC). Despite...
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Ch
[期刊论文] 作者：Puyuan Xing,Di Ma,Qiang Wang,X,
来源：中国癌症研究:英文版 年份：2019
Objective: Crizotinib has demonstrated promising efficacy in patients with anaplastic lymphoma kinase(ALK)-positive non-small-cell lung cancer(NSCLC) in clinica...
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-s
[期刊论文] 作者：Haiyan Xu,Di Ma,Guangjian Yang,Junling Li,Xuezhi Hao,Puyuan Xing,Lu Yang,Fei Xu,Yan Wang,
来源：中国癌症研究（英文版） 年份：2019
...
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Ch
[期刊论文] 作者：Puyuan Xing,Di Ma,Qiang Wang,Xuezhi Hao,Mengzhao Wang,Yan Wang,Li Shan,Tao Xin,Li Liang,Hongge Liang,,
来源：中国癌症研究（英文版） 年份：2019
Objective:Crizotinib has demonstrated promising efficacy in patients with anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) in clinic...
相关搜索：
